Stay updated on Dapagliflozin-Induced Liver Injury Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.

Latest updates to the Dapagliflozin-Induced Liver Injury Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2 with no visible changes to core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedA glossary toggle has been added to the page for quick access to definitions. Footer metadata has been updated, including capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the Revision is now shown as v3.4.0 (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedFooter now shows Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section with Delaware and District of Columbia and updated the page revision to v3.3.3. The prior revision v3.3.2 removed Delaware/DC Locations and the HHS Vulnerability Disclosure.SummaryDifference0.4%

- Check91 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin-Induced Liver Injury Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.